InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
9
T+90 hit rate
0%
T+90 mean return
-31.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Yednock Ted, Directeur Scientifique. Director active across 1 company, notably Annexon, Inc.. Aggregated, 18 reports have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €164k. Activity tracked since 3 June 2021. The latest transaction was disclosed on 27 February 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations18 total
30,646 sharesCommon StockSEC:0001818525-26-000004:0
44,963 shares0Common StockSEC:0001415889-25-006191:0
8,345 shares@ US$2.919.0% of flowCommon StockSEC:0001415889-25-004888:0
1,783 shares@ US$2.992.0% of flowCommon StockSEC:0001415889-25-004432:0
5,408 shares@ US$1.85013.6% of flowCommon StockSEC:0001415889-24-025382:0
4,500 shares@ US$7.1011.1% of flowCommon StockSEC:0001415889-24-023771:0
5,500 shares@ US$6.1611.9% of flowCommon StockSEC:0001415889-24-023441:0
5,500 shares@ US$5.6410.8% of flowCommon StockSEC:0001415889-24-023018:0
5,500 shares@ US$5.9511.5% of flowCommon StockSEC:0001415889-24-022645:0
1,106 shares@ US$6.022.4% of flowCommon StockSEC:0001415889-24-019677:0
39,000 shares0Common StockSEC:0001415889-24-004625:0
1,810 shares@ US$5.543.6% of flowCommon StockSEC:0001415889-24-003854:0
1,057 shares@ US$3.83611.4% of flowCommon StockSEC:0001209191-24-002080:0
10,615 shares@ US$1.40965.3% of flowCommon StockSEC:0001209191-23-059988:0
15,000 shares@ US$1.40960.0021% mcap25.3% of flowCommon StockSEC:0001567619-21-017166:0
15,000 shares@ US$1.40967.0% of flowCommon StockSEC:0001567619-21-017166
15,000 shares@ US$1.40960.0020% mcap24.7% of flowCommon StockSEC:0001567619-21-011776:0
15,000 shares@ US$1.40966.8% of flowCommon StockSEC:0001567619-21-011776
18 of 18 declarations
About Yednock Ted
Ted Yednock serves as Executive Vice President and Chief Scientific Officer at Annexon, Inc. In this role, he oversees the company's research and development activities, ensuring that projects align with strategic objectives. His expertise in biological sciences is essential to support innovation and sustainability within the organization.
